SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001601485-23-000032
Filing Date
2023-05-01
Accepted
2023-05-01 16:14:27
Documents
15
Period of Report
2023-05-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K angn-20230501.htm   iXBRL 8-K 37859
2 EX-99.1 a8k20230501_exhibit991.htm EX-99.1 21368
3 EX-99.2 a8k20230501_exhibit992.htm EX-99.2 2621
7 image.jpg GRAPHIC 584630
  Complete submission text file 0001601485-23-000032.txt   1019361

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20230501.xsd EX-101.SCH 1987
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20230501_lab.xml EX-101.LAB 25136
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20230501_pre.xml EX-101.PRE 13128
9 EXTRACTED XBRL INSTANCE DOCUMENT angn-20230501_htm.xml XML 11404
Mailing Address 7-57 WELLS AVENUE NEWTON MA 02459
Business Address 7-57 WELLS AVENUE NEWTON MA 02459 (857) 336-4001
Angion Biomedica Corp. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 23873822
SIC: 2834 Pharmaceutical Preparations